Gallium arsenide differentially affects processing of phagolysosomal targeted antigen by macrophages

Journal of Leukocyte Biology

Volumn 63, Issue 3, 1998, Pages 321-330

  Lewis, Timothy A ^a   Hartmann, Constance B ^b   McCoy, Kathleen L ^b,c  

^a TRUDEAU INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antigen targeting; Immunotoxicity; Phagocytosis; T cell activation

Indexed keywords

CYTOCHROME; GALLIUM ARSENIDE; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOTOXICITY; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALIA; COLUMBA;

EID: 0031884541     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.3.321     Document Type: Article

References (40)

1. Robinson, A. L. (1983) GaAs readied for high-speed microcircuits. Science 219, 275-277.
2. Harrison, R. J. (1986) Gallium arsenide. State of the art reviews. Occup. Med. 1, 49-58.
3. Sikorski, E. E., McCay, J. A., White, K. L., Jr., Bradley, S. G., Munson, A. E. (1989) Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fund. Appl. Toxicol. 13, 843-858.
4. Sikorski, E. E., Burns, L. A., Stern, M. L., Luster, M. I., Munson, A. E. (1991) Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110, 129-142.
5. Sikorski, E. E., Burns, L. A., McCoy, K. L., Stern, M. L., Munson, A. E. (1991) Suppression of splenic accessory cell function in mice exposed to gallium arsenide. Toxicol. Appl. Pharmacol. 110, 143-156.
6. + T cell activation. J. Pharmacol. Exp. Ther. 278, 1244-1251.
7. Burns, L. A., Spriggs, T. L., Fuchs, B. A., Munson, A. E. (1994) Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response. J. Pharmacol. Exp. Ther. 268, 740-746.
8. Davidson, H. W., West, M. A., Collins, C. (1990) Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/ membrane IgG complexes in B lymphocytes. J. Immunol. 144, 4101-4109.
9. Xu, X., Pierce, S. K. (1995) The novelty of antigen-processing compartments. J. Immunol. 155, 1652-1654.
10. Harding, C. V., Geuze, H. J. (1992) Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J. Cell Biol. 119, 531-542.
11. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L., Geuze, H. J. (1991) Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349, 669-676.
12. + helper T cell stimulation. Toxicol. Appl. Pharmacol. 141, 365-372.
13. Coffman, R. L., Weissman, I. L. (1981) B220: a B cell-specific member of the T200 glycoprotein family. Nature 289, 681-683.
14. Bruce, J., Symington, F. W., McKearn, T. J., Sprent, J. (1981) A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127, 2496-2501.
15. Springer, T. A., Galfr, G., Secher, D. S., Milstein, G. (1979) Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9, 301-306.
16. McCoy, K. L., Gainey, D., Inman, J. K., Stutzman, R. (1993) Antigen presentation by B lymphoma cells: requirements for processing of exogenous antigen internalized through transferrin receptors. J. Immunol. 151, 4583-4594.
17. Samelson, L. E., Germain, R. N., Schwartz, R. H. (1983) Monoclonal antibodies against the antigen receptor on a clone T cell hybrid. Proc. Natl. Acad. Sci. USA 780, 6972-6976.
18. Glimcher, L. G., Hamana, T., Asofsky, R., Heber-Katz, E., Hedrik, S., Schwartz, R. H., Paul, W. E. (1982) I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature 298, 283-284.
19. Baker, P. E., Gillis, S., Smith, K. A. (1979) Monoclonal cytolytic T cell lines. J. Exp. Med. 149, 273-278.
20. Rabin, H., Hopkins, R. F., Ruscetti, F. W., Neubauer, R. H., Brown, R. L., Kawakami, T. G. (1981) Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127, 1852-1856.
21. Merkel, B. J., Mandel, R., Ryser, H. J.-P., McCoy, K. L. (1995) Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds. J. Immunol. 154, 128-136.
22. Ashwell, J. D., Jenkins, M. K., Schwartz, R. H. (1988) Effects of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presenting defect. J. Immunol. 141, 2536-2544.
23. Markwell, M. A. K. (1982) A new solid-state reagent to iodinate proteins. I. Conditions for the efficient iodination of antiserum. Anal. Biochem. 125, 427-432.
24. Safley, S. A., Zeigler, H. K. (1994) Antigen processing and presentation. In Macrophage-Pathogen Interactions (B. S. Zwilling and T. K. Eisenstein, eds.), New York: Marcel Dekker, 115-130.
25. Mellman, I. (1990) Endocytosis and antigen processing. Semin. Immunol. 2, 229-237.
26. Schwartz, R. H., Fox, B. S., Fraga, E., Chen, C., Singh, B. (1985) The T lymphocyte response to cytochrome c. V. Detemination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. J. Immunol. 135, 2598-2608.
27. Chain, B. M., Levine, T. P. (1993) Antigen processing. In Blood Cell Biochemistry, Vol. 5. Macrophages and Related Cells (M. A. Horton, ed.), New York: Plenum Press, 161-182.
28. Bern, W., Alvarez-Dominguez, C., Mayorga, L., Stahl, P. (1995) Membrane trafficking along the phagocytic pathway. Trends Cell Biol. 5, 100-104.
29. Desjardins, M. (1995) Biogenesis of phagolysosomes: the 'kiss and run' hypothesis. Trends Cell Biol. 5, 183-186.
30. Oh, Y.-K., Swanson, J. A. (1996) Different fates of phagocytosed particles after delivery into macrophage lysosomes. J. Cell Biol. 132, 585-593.
31. Bouvier, G., Benoliel, A.-M., Foa, C., Bongrand, P. (1994) Relationship between phagosome acidification, phagosome-lysosome fusion, and mechanism of particle ingestion. J. Leukoc. Biol. 55, 729-734.
32. Webb, D. R., Wilson, S. E., Carter, D. E. (1986) Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide, or arsenic (III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharrmacol. 82, 405-416.
33. Goering, P. L., Maronpot, R. R., Fowler, B. A. (1988) Effect of intractracheal gallium arsenide administration on δ-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid. Toxicol. Appl. Pharmacol. 92, 179-193.
34. Yamauchi, H., Takahashi, K., Yamamura, Y. (1986) Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster. Toxicol. 40, 237-246.
35. Burns, L. A., Sikorski, E. E., Saady, J. J., Munson, A. E. (1991) Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 110, 157-169.
36. Webb, D. R., Spies, I. G., Carter, D. E. (1984) In vitro solubility and in vivo toxicity of gallium arsenide. Toxicol. Appl. Pharmacol. 76, 96-104.
37. Chitamber, C. R., Narasimhan, J., Guy, J., Sem, D. S., O'Brien, W. J. (1991) Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cell. Cancer Res. 51, 6199-6201.
38. Squibb, K. S., Fowler, B. A. (1983) The toxicity of arsenic and its compounds. In Biological and Environmental Effects of Arsenic (B. A. Fowler, ed.), Amsterdam: Elsevier, 233-269.
39. Sheehy, J. W., Jones, J. H. (1993) Assessment of arsenic exposures and controls in gallium arsenide production. Am. Industrial Hygiene Assoc. J. 54, 61-69.
40. Edelman, P. (1990) Environmental and workplace contamination in the semiconductor industry: implications for future health of the workplace and community. Environ. Health Perspect. 86, 291-295.